Several lines of evidence suggest that the risk of ER+ breast cancer increases with estrogen exposure during a women’s lifetime, for example, due to earlier menarche or late menopause (i.e., longer exposure to reproductive hormones due to longer ovarian activity)3. This evidence concerns the gene ESR1 and breast cancer.